Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Small Molecule PPI Mimics LLC
Profile last edited on: 11/12/2019      CAGE: 493Z4      UEI: P43HZLG7V377

Business Identifier: Small molecule therapeutics that perturb protein-protein interactions
Year Founded
2006
First Award
2014
Latest Award
2015
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1203 Munson Avenue Suite B
College Station, TX 77840
   (979) 574-7464
   frontierorbital@gmail.com
   www.smppi.org/index.php
Location: Single
Congr. District: 17
County: Brazos

Public Profile

Small Molecule PPI Mimics LLC is about finding small molecules to perturb protein-protein interaction (PPI). In order to identify small molecules that perturb PPIs the firm uses its method - Exploring Key Orientations (EKO). EKO can be applied in two ways affording customers a competitive advantage by discovery of new chemotypes for a PPI of particular interest and PPIs that could be perturbed by a particular chemotype. The chemotypes are drug-like small molecules, typically designed by Small Molecule PPI Mimics.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$449,800
Phase II Dollars
$0
Total Awarded
$449,800

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2015 1 NIH $225,000
Project Title: Small Molecules to Inhibit PCSK9-LDLR
2014 1 NIH $224,800
Project Title: Eko Approach to Find Small Molecules That Perturb Protein Protein Interaction

Key People / Management

  Kevin Burgess -- CEO

  Charles H Reynolds -- Scientific Officer

Company News

There are no news available.